Tower Research Capital LLC (Trc) Exact Sciences Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Exact Sciences Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,849 shares of EXAS stock, worth $609,171. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,849
Previous 1,104
1063.86%
Holding current value
$609,171
Previous $75,000
861.33%
% of portfolio
0.01%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$831 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$807 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$572 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$572 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$295 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.39B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...